CDK9 keeps RNA polymerase II on track

S Egloff - Cellular and Molecular Life Sciences, 2021 - Springer
Abstract Cyclin-dependent kinase 9 (CDK9), the kinase component of positive transcription
elongation factor b (P-TEFb), is essential for transcription of most protein-coding genes by …

Tackling undruggable targets with designer peptidomimetics and synthetic biologics

CS Swenson, G Mandava, DM Thomas… - Chemical …, 2024 - ACS Publications
The development of potent, specific, and pharmacologically viable chemical probes and
therapeutics is a central focus of chemical biology and therapeutic development. However, a …

Deep structural insights into RNA‐binding disordered protein regions

A Zeke, E Schad, T Horvath… - Wiley …, 2022 - Wiley Online Library
Recent efforts to identify RNA binding proteins in various organisms and cellular contexts
have yielded a large collection of proteins that are capable of RNA binding in the absence of …

Synthetic Peptides: Promising Modalities for the Targeting of Disease‐Related Nucleic Acids

BD Ellenbroek, JP Kahler, SR Evers… - Angewandte …, 2024 - Wiley Online Library
DNA and RNA play pivotal roles in life processes by storing and transferring genetic
information, modulating gene expression, and contributing to essential cellular machinery …

RNet: a network strategy to predict RNA binding preferences

H Liu, Y Jian, J Hou, C Zeng… - Briefings in Bioinformatics, 2024 - academic.oup.com
Determining the RNA binding preferences remains challenging because of the bottleneck of
the binding interactions accompanied by subtle RNA flexibility. Typically, designing RNA …

[HTML][HTML] How 'protein-docking'translates into the new emerging field of docking small molecules to nucleic acids?

F Tessaro, L Scapozza - Molecules, 2020 - mdpi.com
In this review, we retraced the '40-year evolution'of molecular docking algorithms. Over the
course of the years, their development allowed to progress from the so-called 'rigid …

SILCS-RNA: Toward a structure-based drug design approach for targeting RNAs with small molecules

AA Kognole, A Hazel… - Journal of chemical theory …, 2022 - ACS Publications
RNA molecules can act as potential drug targets in different diseases, as their dysregulated
expression or misfolding can alter various cellular processes. Noncoding RNAs account …

Forced intercalation-induced light-up peptides as fluorogenic indicators for the HIV-1 TAR RNA-ligand assay

ETT Lee, Y Sato, AF Ujuagu, S Nishizawa - Analyst, 2024 - pubs.rsc.org
Fluorescence indicators capable of binding to human immunodeficiency virus-1 (HIV-1)
trans-activation responsive (TAR) RNA are powerful tools for the exploratory studies of the …

Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery

SS Chavali, R Bonn-Breach, JE Wedekind - Journal of Biological Chemistry, 2019 - jbc.org
Small molecules and short peptides that potently and selectively bind RNA are rare, making
the molecular structures of these complexes highly exceptional. Accordingly, several recent …

RNA's Dynamic Conformational Selection and Entropic Allosteric Mechanism in Controlling Cascade Protein Binding Events

A Chakraborty, D Samant, R Sarkar… - The journal of …, 2024 - ACS Publications
In the TAR RNA of immunodeficiency viruses, an allosteric communication exists between a
distant loop and a bulge. The bulge interacts with the TAT protein vital for transactivating …